Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT07145957 · ClinicalTrials.gov registry record
Does Undergoing a Prehabilitation Protocol Aimed at Optimizing Scapulothoracic Mobility and Strengthening Improve Internal Rotation After Reverse Shoulder Arthroplasty?
A clinical trial of Primary Reverse Total Shoulder Arthroplasty, sponsored by University of Florida.
- Recruiting
- Registry status
- 64
- Enrollment target
- 1
- Study location
NCT07145957: Recruiting study of Primary Reverse Total Shoulder Arthroplasty, sponsored by University of Florida.
NCT07145957 is a study of Primary Reverse Total Shoulder Arthroplasty that is actively recruiting participants, run by University of Florida. The registered enrollment target is 64 participants. The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT07145957, a study of Primary Reverse Total Shoulder Arthroplasty, is actively recruiting participants, sponsored by University of Florida.
- RECRUITING
- Registry status
- 64 participants
- Enrollment target
- 1
- Study location
Study Summary
Difficulty with internal rotation (IR) after reverse shoulder arthroplasty (RSA) is common. Current rehabilitation protocols may not optimize IR. The investigator's objective is to assess the impact of prehabilitation focused on IR strengthening and mobility on RSA outcomes. The investigators will perform a prospective, randomized control trial to achieve the specific aim: assessing range of motion, strength, patient-reported outcomes, and activities of daily living requiring internal rotation between control and prehabilitation cohorts, with the prehabilitation patients receiving 6 weeks of treatment.
Primary Outcome
Activities of Daily Living questionnaire with a scale of 9 = worst, 100 = best Shoulder Internal Range of Motion Measurements with scoring scale: 0 = Thigh or less.1 = Hip. 2 = Buttocks, 3 =Sacrum, 4 = L4-L5, 5 = L1-L3, 6 = T12-T8, 7 = T7 or Higher
Conditions Studied
Interventions
- OTHER Prehabilitation
Study Locations (1)
Florida
- University of Florida Department of Orthopaedics and Rehabilitation - Gainesville
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 64 participants |
| Start Date | 2025-11-06 |
| Est. Completion | 2028-09-01 |
What NCT07145957 shows while recruiting
NCT07145957 is an observational study that tracks outcomes without assigning an intervention. The registry caps enrollment at 64 participants, a relatively small participant target.
The record links to 1 condition, with Primary Reverse Total Shoulder Arthroplasty appearing as the primary indexed condition, and to 1 intervention - of which Prehabilitation is the first listed.
NCT07145957 reports a single indexed study location in Florida.
Frequently Asked Questions
What is clinical trial NCT07145957 about?
NCT07145957 is a clinical study titled "Does Undergoing a Prehabilitation Protocol Aimed at Optimizing Scapulothoracic Mobility and Strengthening Improve Internal Rotation After Reverse Shoulder Arthroplasty?". Difficulty with internal rotation (IR) after reverse shoulder arthroplasty (RSA) is common. Current rehabilitation protocols may not optimize IR. The investigator's objective is to assess the impact of prehabilitation focused on IR strengthening and mobility on RSA outcomes. The investigators will p...
What is the current status of trial NCT07145957?
This trial is currently recruiting. The enrollment target is 64 participants. The study started on 2025-11-06. Estimated completion is 2028-09-01.
What conditions does trial NCT07145957 study?
This clinical trial studies the following conditions: Primary Reverse Total Shoulder Arthroplasty.
What interventions are being tested in trial NCT07145957?
The interventions under investigation include: Prehabilitation (OTHER).
Who is sponsoring clinical trial NCT07145957?
This trial is sponsored by University of Florida, which has 1,106 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT07145957 being conducted?
This trial has 1 study location across Florida. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT01853631 · 64 participants · Phase 1
Activated T-Cells Expressing 2nd or 3rd Generation CD19-Specific CAR, Advanced B-Cell NHL, ALL, and CLL (SAGAN)
- NCT03739502 · 64 participants · Phase 2
A Randomized Phase II Study of Hyperbaric Oxygen in Improving Engraftment in Umbilical Cord Blood Stem Cell Transplant
- NCT03739814 · 64 participants · Phase 2
Inotuzumab Ozogamicin and Blinatumomab With or Without Ponatinib in Treating Patients With Newly Diagnosed, Recurrent, or Refractory CD22-Positive B-Lineage Acute Lymphoblastic Leukemia
- NCT03866408 · 64 participants · Early Phase 1
Insulin Regulation of Lipolysis and Lipolysis Proteins
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI